To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 26,344 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 0.77% of the total position.
      355Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 2,372 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.66% of the total position.
      72Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 85,021 shares, the number of shares held increased 3.22% compared to the previous period and now represents 1.91% of the total position.
      159Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 18,620 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.37% of the total position.
      28Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 3,066 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.06% of the total position.
      23Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 1,316 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.79% of the total position.
      65Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 11,475 shares, the number of shares held increased 2.36% compared to the previous period and now represents 2.16% of the total position.
      112Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 43,522 shares, the number of shares held increased 2.14% compared to the previous period and now represents 2.31% of the total position.
      18Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 5,054 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 6.52% of the total position.
      121Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 16,688 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 5.43% of the total position.
      1Comment
      Report
       
       
       
       

      Most Discussed